BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38256104)

  • 1. Identification and Validation of a Prognostic Signature Derived from the Cancer Stem Cells for Oral Squamous Cell Carcinoma.
    Shi M; Huang K; Wei J; Wang S; Yang W; Wang H; Li Y
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and validation of a metabolic-related genes prognostic model for oral squamous cell carcinoma based on bioinformatics.
    Zhang J; Ma C; Qin H; Wang Z; Zhu C; Liu X; Hao X; Liu J; Li L; Cai Z
    BMC Med Genomics; 2022 Dec; 15(1):269. PubMed ID: 36566175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Cancer Stem Cell Characteristics and Development of a Prognostic Stemness Index Cell-Related Signature in Oral Squamous Cell Carcinoma.
    Feng J; Li Y; Wen N
    Dis Markers; 2021; 2021():1571421. PubMed ID: 34840626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-495 confers inhibitory effects on cancer stem cells in oral squamous cell carcinoma through the HOXC6-mediated TGF-β signaling pathway.
    You X; Zhou Z; Chen W; Wei X; Zhou H; Luo W
    Stem Cell Res Ther; 2020 Mar; 11(1):117. PubMed ID: 32171324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a lncRNA-based prognostic signature for oral squamous cell carcinoma.
    Xu Z; Li X; Pan L; Tan R; Ji P; Tang H
    J Oral Pathol Med; 2022 Apr; 51(4):358-368. PubMed ID: 35100473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma.
    Zhao C; Zhou Y; Ma H; Wang J; Guo H; Liu H
    BMC Oral Health; 2021 May; 21(1):232. PubMed ID: 33941139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
    Guo H; Li C; Su X; Huang X
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
    Tang Y; Xiao Y; Liao R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel and independent survival prognostic model for OSCC: the functions and prognostic values of RNA-binding proteins.
    Wang S; Liu S; Zhu Y; Zhang B; Yang Y; Li L; Sun Y; Zhang L; Fan L; Hu X; Huang C
    Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):397-409. PubMed ID: 37656222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
    Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
    Front Immunol; 2022; 13():922195. PubMed ID: 35935989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Gene Prognostic Signature for Oral Squamous Cell Carcinoma by RNA Sequencing and Bioinformatics.
    Zhang YY; Mao MH; Han ZX
    Biomed Res Int; 2021; 2021():6657767. PubMed ID: 33869632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an endoplasmic reticulum stress-related prognostic risk model with excellent prognostic and clinical value in oral squamous cell carcinoma.
    Cheng M; Fan X; He M; Dai X; Liu X; Hong J; Zhang L; Liao L
    Aging (Albany NY); 2023 Aug; 15(19):10010-10030. PubMed ID: 37647077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
    Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
    Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
    Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
    Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance, prognostic value and biological role of lncRNA LINC01793 in oral squamous cell carcinoma.
    Yuan SJ; Li SY; Wang YH; Zhang HF; Hua Y; Wang T
    Arch Oral Biol; 2021 May; 125():105105. PubMed ID: 33713982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel pyroptosis-related signature predicts prognosis and indicates immunotherapy in oral squamous cell carcinoma.
    Gao Y; Zhang X; Li Y; Gao J; Liu S; Cai H; Zhang J
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):12057-12070. PubMed ID: 37421458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Prognostic Model Based on Cisplatin-Resistance Related Genes in Oral Squamous Cell Carcinoma.
    Lu R; Yang Q; Liu S; Sun L
    Oral Health Prev Dent; 2024 Jan; 22():39-50. PubMed ID: 38223960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.